CAS 18700-78-2
:1,3,4,5,10-pentahydroxy-2-méthyl-3-[(3-méthyloxiran-2-yl)carbonyl]-1,2,3,4-tétrahydro-4a,9a-époxyanthracène-9(10H)-one
- 1,2,3,4-Tetrahydro-1,3,4,5,10-pentahydroxy-2-methyl-3-[(3-methyloxiranyl)carbonyl]-4a,9a-epoxyanthracen-9(10H)-one
Cervicarcin
CAS :Cervicarcin is a potent inhibitor of human kinases and a promising analog for the treatment of tumors. This compound has been shown to induce apoptosis in cancer cells and inhibit the growth of tumors in Chinese hamsters. Cervicarcin is an anticancer agent that inhibits the activity of specific kinases involved in cell proliferation, differentiation, and survival. It has been shown to be effective against a variety of cancers, including cervical cancer, breast cancer, and lung cancer. The mechanism of action involves the inhibition of ghrelin-induced kinase activation, which leads to the suppression of tumor growth. Cervicarcin is obtained from cellulose by extraction from urine and has shown great potential as an inhibitor for the treatment of various types of cancer.
Formule :C19H20O9Degré de pureté :Min. 95%Masse moléculaire :392.4 g/molCervicarcin
CAS :Cervicarcin is an antitumor antibiotic (antibiotic) exhibiting strong inhibitory effects on sarcoma 180 and sarcoma NF, while showing weaker activity against sarcoma 37, Ehrlich ascites carcinoma, and Freund leukemia.Formule :C19H20O9Couleur et forme :SolidMasse moléculaire :392.357


